Merck (MRK) Announces Robert M Davis to Succeed Kenneth C Frazier as Chairman streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Robert M Davis to Succeed Kenneth C Frazier as Chairman of Merck streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
DURHAM - The entrepreneurial support organization and nonprofit NC IDEA has elected Peyton Anderson as chair of the organization's board of directors, and
Posted on 461
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Kenneth C. Frazier, chairman and chief executive officer, will retire as CEO, effective June 30, 2021. Mr. Frazier will continue to serve on Merck’s board of directors as executive chairman, for a transition period to be determined by the board. The Merck board of directors has unanimously elected Robert M. Davis, Merck’s current executive vice president, global services and chief financial officer, as chief executive officer, as well as a member of the board, effective July 1, 2021. Mr. Davis will become president of Merck, effective April 1, 2021, at which time the company’s operating divisions Human Health, Animal Health, Manufacturing, and Merck Research Laboratories will begin reporting to him.